Cargando…

Evaluation of aerosol drug delivery with concurrent low- and high-flow nasal oxygen

QUESTION ADDRESSED BY STUDY: Administration of aerosol to patients receiving high-flow nasal oxygen (HFNO) ranges from concurrent aerosol delivery by mouthpiece to aerosol via cannula alone. This study examines the conditions to provide optimal aerosol delivery with low- or high-flow nasal oxygen wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murphy, Barry, Eain, Marc Mac Giolla, Joyce, Mary, Fink, James B., MacLoughlin, Ronan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549318/ https://www.ncbi.nlm.nih.gov/pubmed/36225335 http://dx.doi.org/10.1183/23120541.00220-2022

Ejemplares similares

Exhaled patient derived aerosol dispersion during awake tracheal intubation with concurrent high flow nasal therapy
por: Eain, Marc Mac Giolla, et al.
Publicado: (2023)

The Impact of Head Model Choice on the In Vitro Evaluation of Aerosol Drug Delivery
por: Gallagher, Lauren, et al.
Publicado: (2021)

An in vitro visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021)

In vitro evaluation of disposable transport ventilators with combination aerosol therapy
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021)

Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy
por: Bennett, Gavin, et al.
Publicado: (2019)

Evaluation of Aerosol Drug Delivery Options during Adult Mechanical Ventilation in the COVID-19 Era
por: Naughton, Piers J., et al.
Publicado: (2021)

Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021)

In Vitro Study of the Effect of Breathing Pattern on Aerosol Delivery During High-Flow Nasal Therapy
por: Bennett, Gavin, et al.
Publicado: (2019)

A narrative review on trans-nasal pulmonary aerosol delivery
por: Li, Jie, et al.
Publicado: (2020)

In Vitro Determination of the Main Effects in the Design of High-Flow Nasal Therapy Systems with Respect to Aerosol Performance
por: Bennett, Gavin, et al.
Publicado: (2018)

Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation
por: Joyce, Mary, et al.
Publicado: (2021)

In vitro model for investigating aerosol dispersion in a simulated COVID-19 patient during high-flow nasal cannula treatment
por: McGrath, James A., et al.
Publicado: (2022)

State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery
por: Brave, Hosanna, et al.
Publicado: (2020)

Distribution of Droplets and Immune Responses After Aerosol and Intra-Nasal Delivery of Influenza Virus to the Respiratory Tract of Pigs
por: Martini, Veronica, et al.
Publicado: (2020)

Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease
por: Woods, Niamh, et al.
Publicado: (2020)

Investigation of Fugitive Aerosols Released into the Environment during High-Flow Therapy
por: McGrath, James A., et al.
Publicado: (2019)

Can high efficiency aerosol delivery continue after extubation?
por: Fink, J, et al.
Publicado: (2005)

Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis
por: Fernández Fernández, Elena, et al.
Publicado: (2021)

Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation
por: McGrath, James A., et al.
Publicado: (2019)

Advancing mesenchymal stem cell therapy for asthma towards clinical translation
por: MacLoughlin, Ronan
Publicado: (2022)

The Ratio of Nasal Cannula Gas Flow to Patient Inspiratory Flow on Trans-nasal Pulmonary Aerosol Delivery for Adults: An in Vitro Study
por: Li, Jie, et al.
Publicado: (2019)

Molecular Insight into the Therapeutic Effects of Stem Cell-Derived Exosomes in Respiratory Diseases and the Potential for Pulmonary Delivery
por: Azhdari, Mohammad H., et al.
Publicado: (2022)

Aerosolized Pulmonary Delivery of mRNA Constructs Attenuates Severity of Escherichia coli Pneumonia in the Rat
por: McCarthy, Sean D., et al.
Publicado: (2023)

The effect of UV-protected ethylene vinyl acetate (EVA) bags on the physicochemical stability of pediatric parenteral nutrition admixtures
por: Watrobska-Swietlikowska, Dorota, et al.
Publicado: (2019)

Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine
por: Fink, James B., et al.
Publicado: (2020)

Cellular Immunotherapy and the Lung
por: Daly, Sorcha, et al.
Publicado: (2021)

In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8/CxCL-1 siRNA Delivery to the Lungs
por: Hibbitts, Alan J., et al.
Publicado: (2020)

Is High-Flow Nasal Cannula Oxygen Therapy an Aerosol-Generating Medical Procedure?
por: Hamada, Satoshi, et al.
Publicado: (2021)

Is High-Flow Nasal Cannula Oxygen Therapy an Aerosol-Generating Medical Procedure?
por: Hamada, Satoshi, et al.
Publicado: (2021)

High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion
por: Li, Jie, et al.
Publicado: (2020)

Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects
por: Sécher, Thomas, et al.
Publicado: (2022)

Cellular Therapy for the Treatment of Paediatric Respiratory Disease
por: Brennan, Laura C., et al.
Publicado: (2021)

Humidification via high-flow nasal cannula oxygen therapy does not generate aerosols
por: Hamada, Satoshi, et al.
Publicado: (2021)

High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
por: Li, Jie, et al.
Publicado: (2020)

Indigenous adaptor for high flow nasal oxygen delivery
por: Thakur, Nagarjuna, et al.
Publicado: (2022)

Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases
por: Paudel, Keshav Raj, et al.
Publicado: (2022)

Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study
por: Wallin, Martin, et al.
Publicado: (2019)

Aerosol delivery through high-flow nasal therapy: Technical issues and clinical benefits
por: Calabrese, Cecilia, et al.
Publicado: (2023)

Airborne particle dispersion by high flow nasal oxygen: An experimental and CFD analysis
por: Crowley, Caroline, et al.
Publicado: (2022)

Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trial
por: Li, Jie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2j6m8lup3226furbm2chkap4d1